Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Robert H. Vonderheide, MD, DPhil
Dr. Robert Vonderheide is the John H. Glick Abramson Cancer Center professor at the University of Pennsylvania’s… -
CRI Funded Scientist
Tal Danino, PhD
Immunotherapy is poised to overcome several current limitations for successful interventions against advanced cancers. Dr. William B. Coley,… -
CRI Funded Scientist
Greg M. Delgoffe, PhD
The landscape of cancer treatment has been fundamentally changed by advances in immunotherapy: bolstering or augmenting the… -
CRI Funded Scientist
Marie Anne Vetizou, PhD
-
CRI Funded Scientist
Chao Yang, PhD
-
CRI Funded Scientist
Andrea Schietinger, PhD
As an inaugural CRI Lloyd J. Old STAR, Dr. Andrea Schietinger is working to better characterize the… -
CRI Funded Scientist
Amanda Poisonnier, PhD
-
CRI Funded Scientist
Ansuman T. Satpathy, MD, PhD
The goal of Dr. Satpathy’s research is to develop and apply genome-scale technologies to study fundamental properties… -
CRI Funded Scientist
Kazuki Kato, PhD
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.